Shopping Cart
Remove All
Your shopping cart is currently empty
Zuberitamab (Synonyms: HS006)
Catalog No. T76946 Copy Product Info
🥰Excellent
Zuberitamab (HS-20090) is a humanized IgG1 monoclonal antibody targeting CD20. The compound specifically binds to CD20 on the surface of B cells, facilitating the depletion of malignant B cells through antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and the direct induction of apoptosis. In experimental studies, Zuberitamab serves as a potent tool for B-cell depletion to investigate hematological malignancies such as Non-Hodgkin Lymphoma (NHL).
Zuberitamab
Copy Product Info🥰Excellent
Catalog No. T76946
Synonyms HS006
Zuberitamab (HS-20090) is a humanized IgG1 monoclonal antibody targeting CD20. The compound specifically binds to CD20 on the surface of B cells, facilitating the depletion of malignant B cells through antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and the direct induction of apoptosis. In experimental studies, Zuberitamab serves as a potent tool for B-cell depletion to investigate hematological malignancies such as Non-Hodgkin Lymphoma (NHL).
Zuberitamab
Cas No. 2251143-19-6
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 5 mg | Inquiry | Inquiry | Inquiry |
For In stock only · Estimated delivery: USA Stock (1-2 days) Global Stock (5-7 days)
Add to Quotation
For research use only—not for human use. No sales to individuals. Use as intended only.
Resource Download
Product Introduction
Bioactivity
Related Conjugates and Formulations
Antigen Details
Chemical Properties
Antibody Information
Storage & Solubility Information
| Description | Zuberitamab (HS-20090) is a humanized IgG1 monoclonal antibody targeting CD20. The compound specifically binds to CD20 on the surface of B cells, facilitating the depletion of malignant B cells through antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and the direct induction of apoptosis. In experimental studies, Zuberitamab serves as a potent tool for B-cell depletion to investigate hematological malignancies such as Non-Hodgkin Lymphoma (NHL). |
| Synonyms | HS006 |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Formulation | Supplied as a sterile solution in a buffered formulation system (e.g., phosphate-, citrate-, or amino acid-based). Please refer to the CoA for lot-specific composition. |
| Endotoxin | <1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID | |
| Target | CD20 |
| Cas No. | 2251143-19-6 |
| Isotype | IgG1 |
| Storage | store at low temperature | store at -20°C | Shipping with blue ice/Shipping at ambient temperature. |
Calculator
Preview
Related Tags: buy Zuberitamab | purchase Zuberitamab | Zuberitamab cost | order Zuberitamab
Generate Quote
Catalog No.: Cas No.:
Add
| Size | Quantity | Unit Price | Amount | Operation |
|---|
Generate Quote
- TOP
Feedback
Hello! How can I help you today? 
Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.